VYNE Therapeutics (VYNE)

• Market cap: $19.7M
• 1 day: -4.26%
• 5 days: -4.65%
• 1 month: -1.53%
• 3 months: 5.27%
• 6 months: 79.7%
• Year to date: 1.95%
• 1 year: -66.79%
• 5 years: -99.49%
• 10 years: -99.97%
• Sector: Healthcare
• Industry: Biotechnology

About: VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

Employees: 10